ACADIA Pharmaceuticals, Inc. (ACAD)
24.56
-0.08
(-0.32%)
USD |
NASDAQ |
Feb 27, 16:00
24.54
-0.02
(-0.06%)
After-Hours: 20:00
ACADIA Pharmaceuticals Research and Development Expense (Annual) : 328.80M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Insmed, Inc. | 771.09M |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| Marker Therapeutics, Inc. | 13.47M |
| Agilent Technologies, Inc. | 450.00M |
| BioMarin Pharmaceutical, Inc. | 700.97M |